Skip to main content
. 2023 Feb 2;14:1113932. doi: 10.3389/fimmu.2023.1113932

Figure 6.

Figure 6

Severe COVID-19 patients with hypertension have greater frequencies of CD62L+ CD4+ T cells. The frequencies of CD4+ (A) and CD8+ T cells (viable, CD14-, CD56-, CD19-, CD3+, CD4+ or CD8+ cells) (B) expressing CD62L in severe and non-severe COVID-19 patients with or without hypertension were assessed by flow cytometry. *p<0.05, **p<0.01 one-way ANOVA with multiple comparisons correction.